3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
6
Temozolomide
3
Biopsy
3
Bevacizumab
3
posaconazole
2
fluciclovine F-18
2
Topotecan
2
Specimen Handling
2
Radiosurgery
2
Pemetrexed
2
Nivolumab
2
Methotrexate
2
Ketoconazole
2
Fluorodeoxyglucose F18
2
ribociclib
1
relatlimab
1
mycophenolic adenine dinucleotide
1
montelukast
1
gancotamab
1
fluoromisonidazole
1
fluorodopa F 18
1
fludarabine phosphate
1
etoposide phosphate
1
eribulin
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
clevudine
1
ceritinib
1
brivaracetam
1
auricularum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Brain Neoplasms
×
Nutritional Status
×
Clear all
NCT01770626
2014-10-28
BEAM
University of Alabama at Birmingham
Phase EARLY_PHASE1
Completed
40 enrolled